# Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease

> **NCT00598637** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 650 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DEVICE:** Everolimus-eluting stent (Xience)
- **DEVICE:** Zotarolimus-eluting stent (Endeavor Resolute)

## Key facts

- **NCT ID:** NCT00598637
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2012-09
- **Final completion:** 2013-02
- **Target enrollment:** 650 (ACTUAL)
- **Last updated:** 2013-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598637, "Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00598637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*